Bloodline Theatre Company’s new play Panacea doesn’t just ask what science can do — it asks what it should…
Written by microbiologist Singer and theatre-maker James, this debut collaboration examines the ethical grey zones of innovation through the story of Augustus “Gus” Jameson, a young scientist developing an infectious vaccine — one that could save lives or rob humanity of choice.
Premiered at London’s Cockpit Theatre in January, the play now embarks on a short national run, visiting Birmingham’s Midlands Arts Centre (17 November) and Liverpool’s Hope Street Theatre (27 November) before returning to London later this month.
Science on stage, ethics in the spotlight
At its heart, Panacea is a moral thriller disguised as a love story — Gus’s idealism, ambition and desire collide as his breakthrough spirals into questions of control, accountability and the limits of human responsibility. As antibiotics falter and new pathogens emerge, the premise feels alarmingly prescient.
Singer and James drew inspiration from their respective worlds — the lab and the rehearsal room — to explore how science and art might illuminate one another. “The idea of an infectious vaccine — something that spreads autonomously — is no longer theoretical,” Singer notes. “It raises urgent ethical questions about consent, governance and what it means to ‘protect’ humanity.”
Bridging two worlds
Director Isabelle Tyner, a RADA and Birkbeck alumna whose past work includes the award-winning Sitting (In Silence), says the production demanded an unusual balance:
“We’ve loved the challenge of bringing the science and theatre worlds together. Panacea has its finger on the pulse of contemporary science — but it’s also deeply human, about love, fear and the need to do good.”
Tyner’s direction draws on a chorus-led structure that mirrors Gus’s fractured psyche, with Jonty O’Callaghan in the lead role, joined by Marianne James, Nina Fidderman, Gwilym Roberts, Charlie Culley and Emily Wallace.
Science funding meets stagecraft
In a rare collaboration between research and performance, the production is supported by Digital Health Hub for AMR and ARREST-AMR, both UKRI-funded projects under the EPSRC and BBSRC. Their investment reflects a growing interest in the arts as a tool for public engagement with complex scientific issues.
Singer and James — who continue to collaborate across science, policy and the arts — describe Panacea as “a vehicle for communicating science in an accessible way.” By grounding molecular ethics in human emotion, it brings a laboratory debate to the stage without losing its pulse.
Panacea on tour
Birmingham | Midlands Arts Centre | 17 November (19:30)
